Marco Coazzoli Selected Research

gibbilimbol B

9/2019

XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Coazzoli Research Topics

Disease

2	Melanoma (Melanoma, Malignant) 01/2020 - 12/2018
2	Neoplasms (Cancer) 09/2019 - 01/2018
1	Obesity 01/2022
1	Inflammation (Inflammations) 11/2021
1	Muscular Diseases (Myopathy) 02/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2019
1	Acidosis 01/2019

Drug/Important Bio-Agent (IBA)

3	AcidsIBA 01/2022 - 01/2018
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2022 - 01/2018
2	EnzymesIBA 11/2021 - 01/2020
2	climacostolIBA 01/2019 - 12/2018
1	DystrophinIBA 02/2021
1	Retinaldehyde (Retinal)IBA 02/2021
1	gibbilimbol BIBA 09/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2019
1	CaspasesIBA 09/2019
1	X-Linked Inhibitor of Apoptosis ProteinIBA 09/2019
1	Biological ProductsIBA 01/2019
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Serine (L-Serine)FDA Link 01/2018